Aug 21 (Reuters) - Monsenso A/S MONSO.CO :
* MONSENSO SIGNS NEW AGREEMENT TO SUPPORT GLOBAL PHARMACEUTICAL ACROSS NINE EUROPEAN
COUNTRIES
* MONSENSO'S MOBILE HEALTH SOLUTION WILL BE USED FOR REAL-WORLD DATA COLLECTION ACROSS TWO
STUDIES
IN CONNECTION WITH LAUNCH OF A NEW DRUG FOR DEPRESSION TREATMENT
* STUDIES ARE EXPECTED TO START IN FIRST HALF OF 2021 AND WILL RUN OVER A THREE-YEAR PERIOD,
* PROJECT WILL NOT AFFECT MONSENSO'S PREVIOUSLY COMMUNICATED PLANS AND GUIDANCE FOR 2020
FINANCIAL
YEAR
* FOLLOWING A YEAR-LONG COLLABORATION, MONSENSO SIGNS A THREE-YEAR +10 MIO DKK AGREEMENT
WITH A
GLOBAL PHARMACEUTICAL COMPANY
Source text: https://bit.ly/34j1Y7n
Further company coverage: MONSO.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))